7月22日，丹纳赫盘中下跌3.34%，报173.0美元/股，成交额3.69亿美元，延续前一交易日财报发布后的抛售态势。
消息面上，公司于7月21日盘前发布二季度财报，虽业绩全面超预期——非GAAP每股收益1.94美元（预期1.83美元），营收62.65亿美元（预期61.02亿美元），全年EPS指引上调至8.45-8.60美元，但三季度非GAAP核心收入同比增速仅指引2.0%-3.0%，增长显著放缓成为市场抛售主因。财报发布后，多家机构密集下调目标价：Morgan Stanley由255美元降至220美元，Evercore ISI由230美元降至205美元，进一步压制市场情绪。此外，公司近期完成对Masimo约100亿美元的收购及旗下徕卡生物系统收购StatLab，频繁并购整合亦加重市场对短期财务压力的担忧。
（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.